Use of HMGB proteins and nucleic acids that code therefor
Details for Australian Patent Application No. 2002358771 (hide)
International Classifications
Event Publications
3 April 2003 Complete Application Filed
Priority application(s): 101 62 556.1 19.12.01 DE
28 August 2003 Application Open to Public Inspection
Published as AU-B-2002358771
23 April 2009 Application Accepted
Published as AU-B-2002358771
23 July 2009 Application for Amendment
The nature of the amendment is: Amend the name of the inventor from Bullerdiek, Jorn to Bullerdiek, Joern. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2003
23 July 2009 Alteration of Name
The name of the applicant has been altered to alcedo biotech GmbH 2003
12 November 2009 Amendment Made
The nature of the amendment is: Amend the name of the inventor from Bullerdiek, Jorn to Bullerdiek, Joern
19 November 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002358772-Pyrrolidine derivatives as prostaglandin modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser